I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

An announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...

The sNDA seeks approval for the treatment of relapsed or refractory (R/R) mutant NPM1 (mNPM1) acute myeloid leukemia/AML. The ...

Cero will use Invivoscribe's multiparametric flow cytometry assay to detect minimal residual disease in patients and evaluate the therapy's efficacy.

After a leukemia diagnosis, a Rome family found support at an Atlanta Ronald McDonald House while their son underwent chemotherapy at Children’s Healthcare of Atlanta.

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

"I don't want her to lose anything, ever. I feel very married to what Charlotte wants," Kristin Davis tells THR about season ...

ELLSWORTH — Runners, walkers and strollers are welcome at the Kinsley Ray 5K run and walk on Saturday, July 26. The annual ...

Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment ...

Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.

But recent medical breakthroughs-including the recent approval of targeted therapies in India like Ivosidenib for IDH1 mutated AML - may change the narrative. "Acute Myeloid Leukemia is a disease ...